WAYNE, Pa.--(BUSINESS WIRE)--Safeguard Scientifics, Inc. (NYSE: SFE), a holding company that builds value in growth-stage technology and life sciences companies, today announced its financial results for the first quarter 2008. Safeguard reported consolidated revenue of $15.9 million for the first quarter, an 80% increase as compared to $8.8 million in the first quarter of 2007, as adjusted for discontinued operations. Safeguard’s consolidated net loss for the first quarter was $11.5 million, compared to a net loss of $8.9 million in the first quarter of 2007, excluding discontinued operations. Discontinued operations represent results from Safeguard’s majority-held partner companies Acsis, Inc., Alliance Consulting Group Associates, Inc. and Laureate Pharma, Inc. and in Q1 2007 also include the results of Pacific Title & Art Studio and Clarient’s former technology group.
